No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials.
<h4>Background and objectives</h4>Statins showed mixed results in heart failure (HF) patients. The benefits in major HF outcomes, including all-cause mortality and sudden cardiac death (SCD), have always been discordant across systematic reviews and meta-analyses. We intended to systemat...
Main Authors: | Muaamar Al-Gobari, Hai-Ha Le, Mor Fall, François Gueyffier, Bernard Burnand |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0171168 |
Similar Items
-
Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
by: Hai-Ha Le, et al.
Published: (2016-01-01) -
Risk stratification of sudden cardiac death in heart failure patients: is left ventricular ejection fraction alone sufficient?
by: N. N. Ilov, et al.
Published: (2021-02-01) -
Osteopontin and LDLR Are Upregulated in Hearts of Sudden Cardiac Death Victims With Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus
by: Mausam Patel, et al.
Published: (2020-11-01) -
Heart Failure with Preserved Ejection Fraction and Sudden Death: How to Identify High Risk Patients?
by: Bruno Schaaf Finkler, et al.
Published: (2020-06-01) -
Loss of skeletal muscle mass predicts cardiac death in heart failure with a preserved ejection fraction but not heart failure with a reduced ejection fraction
by: Koichiro Matsumura, et al.
Published: (2020-12-01)